# Safety, Tolerability and Pharmacokinetics of Multiple Doses of ZGN-433 in Obese Female Volunteers

> **NCT01028261** · PHASE1 · COMPLETED · sponsor: **Zafgen, Inc.** · enrollment: 31 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** ZGN-433

## Key facts

- **NCT ID:** NCT01028261
- **Lead sponsor:** Zafgen, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2012-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01028261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01028261, "Safety, Tolerability and Pharmacokinetics of Multiple Doses of ZGN-433 in Obese Female Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01028261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*